EyePoint sues Ocular Therapeutix, alleging false statements about Duravyu and company conduct
EyePoint Pharmaceuticals filed a complaint in Middlesex County Superior Court on March 20, accusing Ocular Therapeutix of disseminating false or misleading statements about EyePoint and its experimental eye drug Duravyu. The suit seeks injunctive relief, a public retraction, and monetary damages and legal fees. Ocular said it stands by its statemen…